Insulin Delivery Devices Market Size, Share, Trends, Growth Outlook

Insulin Delivery Devices Market is estimated to increase at a Compounded Annual Growth Rate of 8.1% CAGR over the forecast period from 2024 to 2030

The Insulin Delivery Devices Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Type (Insulin Pens, Insulin Pumps, Insulin Pen Needles, Insulin Syringes, Others), By End-User (Home Care, Hospitals, Clinics, Others).

An Introduction to Insulin Delivery Devices Market in 2024

Insulin delivery devices are medical devices used to administer insulin, a hormone essential for the management of diabetes, via subcutaneous injection or continuous infusion. In 2024, insulin delivery devices continue to evolve to meet the diverse needs and preferences of individuals with diabetes, offering advanced features, improved usability, and enhanced integration with digital health technologies. Insulin delivery devices encompass a range of devices, including insulin pens, insulin pumps, insulin patch pumps, and insulin jet injectors, each with unique advantages and considerations for insulin administration. Insulin pens are pen-shaped devices that hold insulin cartridges or disposable insulin vials and are used to deliver rapid-acting, short-acting, intermediate-acting, or long-acting insulin analogs via subcutaneous injection. Insulin pumps are wearable devices that deliver a continuous infusion of rapid-acting insulin around the clock, mimicking the physiological basal insulin secretion of the pancreas, with additional bolus doses administered at meal times or to correct high blood sugar levels. Insulin patch pumps are patch-like devices worn on the skin that deliver rapid-acting insulin via a small cannula inserted into the subcutaneous tissue, offering discreet and needle-free insulin delivery. Insulin jet injectors use high-pressure air or gas to deliver insulin through the skin without the need for needles, offering an alternative for individuals who have needle phobia or difficulty with manual injections. With advancements in insulin delivery device technology, patients with diabetes have access to features such as wireless connectivity, smartphone integration, automated insulin delivery algorithms, and continuous glucose monitoring (CGM) integration, allowing for personalized and data-driven insulin therapy management. Additionally, insulin delivery devices are designed to enhance patient convenience, improve insulin dosing accuracy, reduce hypoglycemia risk, and promote adherence to insulin therapy regimens. By providing patients with flexible and user-friendly options for insulin administration, insulin delivery devices support diabetes self-management, improve glycemic control, and enhance the overall quality of life for individuals living with diabetes.

Market Trend: Integration of Smart Technology

A significant trend in the insulin delivery devices market is the integration of smart technology. With the increasing prevalence of diabetes and the growing demand for personalized healthcare solutions, there is a rising interest in insulin delivery devices that incorporate smart features such as connectivity, data tracking, and dose monitoring. These devices, including smart insulin pens, insulin pumps, and continuous glucose monitoring (CGM) systems, enable patients to monitor their blood glucose levels, track insulin dosing, and receive real-time feedback on their treatment regimen. Additionally, the integration of artificial intelligence (AI) and machine learning algorithms allows for personalized insulin dosing recommendations based on individual glucose levels, meal patterns, and activity levels. As patients and healthcare providers seek more sophisticated tools for diabetes management, the adoption of smart insulin delivery devices is expected to continue to grow, driving market expansion and innovation in connected diabetes care solutions.

Market Driver: Rising Global Prevalence of Diabetes

A key driver fueling the insulin delivery devices market is the rising global prevalence of diabetes. Diabetes has become a major public health concern worldwide, with millions of people affected by the condition and its associated complications. The increasing prevalence of obesity, sedentary lifestyles, and unhealthy dietary habits contributes to the growing incidence of type 1 and type 2 diabetes. As a result, there is a growing need for effective insulin delivery devices to help patients manage their blood glucose levels and prevent diabetes-related complications. Insulin delivery devices such as insulin pens, insulin pumps, and patch pumps offer advantages such as precise dosing, convenience, and flexibility in insulin administration, making them essential tools for diabetes management. With the rising demand for diabetes care solutions and the emphasis on early detection and intervention, the market for insulin delivery devices is expected to expand, driven by the growing diabetic population and the need for innovative diabetes management strategies.

Market Opportunity: Development of Closed-loop Insulin Delivery Systems

A potential opportunity in the insulin delivery devices market lies in the development of closed-loop insulin delivery systems, also known as artificial pancreas systems. Closed-loop systems combine insulin delivery devices with continuous glucose monitoring (CGM) sensors and automated algorithms to provide real-time insulin dosing adjustments based on glucose levels. These systems offer the promise of improved glycemic control, reduced hypoglycemia risk, and enhanced quality of life for individuals with diabetes. By automatically adjusting insulin doses in response to changes in blood glucose levels, closed-loop insulin delivery systems mimic the function of the human pancreas and provide more personalized and precise insulin therapy. Additionally, closed-loop systems have the potential to alleviate the burden of diabetes management for patients and caregivers by simplifying insulin dosing decisions and reducing the need for frequent blood glucose monitoring and manual insulin adjustments. With ongoing advancements in sensor technology, insulin pump design, and algorithm optimization, there is an opportunity for manufacturers to develop next-generation closed-loop insulin delivery systems that offer improved safety, efficacy, and usability for patients with diabetes. Expanding into closed-loop insulin delivery presents a strategic opportunity for stakeholders to address unmet medical needs, drive innovation, and transform the landscape of diabetes care.

Insulin Delivery Devices Market Share Analysis: Insulin Pens is the fastest growing segment over the forecast period to 2030

Among the segments of the Insulin Delivery Devices Market, Insulin Pens emerge as the fastest-growing category. This accelerated growth is propelled by several factors. Insulin pens offer numerous advantages over traditional insulin delivery methods such as syringes, including ease of use, convenience, and portability. The availability of both reusable and disposable insulin pen options caters to the diverse needs and preferences of patients with diabetes, leading to increased adoption in both home care and clinical settings. Furthermore, advancements in insulin pen technology, such as improved dosing accuracy, enhanced ergonomic designs, and integrated features like dose memory and dose titration, further drive their popularity among healthcare providers and patients alike. Moreover, the growing emphasis on self-management and patient empowerment in diabetes care fuels the demand for insulin pens, as they enable patients to administer insulin with greater autonomy and confidence. As the prevalence of diabetes continues to rise globally, driving the need for effective and convenient insulin delivery solutions, the Insulin Pens segment experiences rapid growth, positioning it as a key driver in the Insulin Delivery Devices Market.

Insulin Delivery Devices Competitive Analysis

The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossBiocon Ltd, Ceuru Corp, Debiotech SA, Eli Lilly and Company, Embecta Corp, EoFlow CO. Ltd, Haselmeier GmbH, Hindustan Syringes & Medical Devices Ltd, HTL-STREFA S.A., Insulet Corp, Jiangsu Delfu Medical Device Co. Ltd, MannKind Corp, Medtronic Inc, Medtrum Technologies Inc, Novo Nordisk A/S, Owen Mumford Ltd, Roche Diabetes Care Inc, Sanofi S.A., Sooil Developments Co. Ltd, Sungshim Medical Co. Ltd, Tandem Diabetes Care Inc, Terumo Corp, Vicentra B.V., Wockhardt Ltd, Ypsomed Holding AG

Insulin Delivery Devices Market Segmentation

By Type
Insulin Pens
-Reusable Insulin Pens
-Disposable Insulin Pens
Insulin Pumps
-Tethered Insulin Pumps
-Tubeless Insulin Pumps
Insulin Pen Needles
-Standard Insulin Pen Needles
-Safety Insulin Pen Needles
Insulin Syringes
Others
By End-User
Home Care
Hospitals
Clinics
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Insulin Delivery Devices Market Companies

Biocon Ltd
Ceuru Corp
Debiotech SA
Eli Lilly and Company
Embecta Corp
EoFlow CO. Ltd
Haselmeier GmbH
Hindustan Syringes & Medical Devices Ltd
HTL-STREFA S.A.
Insulet Corp
Jiangsu Delfu Medical Device Co. Ltd
MannKind Corp
Medtronic Inc
Medtrum Technologies Inc
Novo Nordisk A/S
Owen Mumford Ltd
Roche Diabetes Care Inc
Sanofi S.A.
Sooil Developments Co. Ltd
Sungshim Medical Co. Ltd
Tandem Diabetes Care Inc
Terumo Corp
Vicentra B.V.
Wockhardt Ltd
Ypsomed Holding AG

Reasons to Buy the Insulin Delivery Devices Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Insulin Delivery Devices Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Insulin Delivery Devices Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Insulin Delivery Devices Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Insulin Delivery Devices Market Size Outlook, $ Million, 2021 to 2030
3.2 Insulin Delivery Devices Market Outlook by Type, $ Million, 2021 to 2030
3.3 Insulin Delivery Devices Market Outlook by Product, $ Million, 2021 to 2030
3.4 Insulin Delivery Devices Market Outlook by Application, $ Million, 2021 to 2030
3.5 Insulin Delivery Devices Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Insulin Delivery Devices Industry
4.2 Key Market Trends in Insulin Delivery Devices Industry
4.3 Potential Opportunities in Insulin Delivery Devices Industry
4.4 Key Challenges in Insulin Delivery Devices Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Insulin Delivery Devices Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Insulin Delivery Devices Market Outlook by Segments
7.1 Insulin Delivery Devices Market Outlook by Segments, $ Million, 2021- 2030
By Type
Insulin Pens
-Reusable Insulin Pens
-Disposable Insulin Pens
Insulin Pumps
-Tethered Insulin Pumps
-Tubeless Insulin Pumps
Insulin Pen Needles
-Standard Insulin Pen Needles
-Safety Insulin Pen Needles
Insulin Syringes
Others
By End-User
Home Care
Hospitals
Clinics
Others

8 North America Insulin Delivery Devices Market Analysis and Outlook To 2030
8.1 Introduction to North America Insulin Delivery Devices Markets in 2024
8.2 North America Insulin Delivery Devices Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Insulin Delivery Devices Market size Outlook by Segments, 2021-2030
By Type
Insulin Pens
-Reusable Insulin Pens
-Disposable Insulin Pens
Insulin Pumps
-Tethered Insulin Pumps
-Tubeless Insulin Pumps
Insulin Pen Needles
-Standard Insulin Pen Needles
-Safety Insulin Pen Needles
Insulin Syringes
Others
By End-User
Home Care
Hospitals
Clinics
Others

9 Europe Insulin Delivery Devices Market Analysis and Outlook To 2030
9.1 Introduction to Europe Insulin Delivery Devices Markets in 2024
9.2 Europe Insulin Delivery Devices Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Insulin Delivery Devices Market Size Outlook by Segments, 2021-2030
By Type
Insulin Pens
-Reusable Insulin Pens
-Disposable Insulin Pens
Insulin Pumps
-Tethered Insulin Pumps
-Tubeless Insulin Pumps
Insulin Pen Needles
-Standard Insulin Pen Needles
-Safety Insulin Pen Needles
Insulin Syringes
Others
By End-User
Home Care
Hospitals
Clinics
Others

10 Asia Pacific Insulin Delivery Devices Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Insulin Delivery Devices Markets in 2024
10.2 Asia Pacific Insulin Delivery Devices Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Insulin Delivery Devices Market size Outlook by Segments, 2021-2030
By Type
Insulin Pens
-Reusable Insulin Pens
-Disposable Insulin Pens
Insulin Pumps
-Tethered Insulin Pumps
-Tubeless Insulin Pumps
Insulin Pen Needles
-Standard Insulin Pen Needles
-Safety Insulin Pen Needles
Insulin Syringes
Others
By End-User
Home Care
Hospitals
Clinics
Others

11 South America Insulin Delivery Devices Market Analysis and Outlook To 2030
11.1 Introduction to South America Insulin Delivery Devices Markets in 2024
11.2 South America Insulin Delivery Devices Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Insulin Delivery Devices Market size Outlook by Segments, 2021-2030
By Type
Insulin Pens
-Reusable Insulin Pens
-Disposable Insulin Pens
Insulin Pumps
-Tethered Insulin Pumps
-Tubeless Insulin Pumps
Insulin Pen Needles
-Standard Insulin Pen Needles
-Safety Insulin Pen Needles
Insulin Syringes
Others
By End-User
Home Care
Hospitals
Clinics
Others
12 Middle East and Africa Insulin Delivery Devices Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Insulin Delivery Devices Markets in 2024
12.2 Middle East and Africa Insulin Delivery Devices Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Insulin Delivery Devices Market size Outlook by Segments, 2021-2030
By Type
Insulin Pens
-Reusable Insulin Pens
-Disposable Insulin Pens
Insulin Pumps
-Tethered Insulin Pumps
-Tubeless Insulin Pumps
Insulin Pen Needles
-Standard Insulin Pen Needles
-Safety Insulin Pen Needles
Insulin Syringes
Others
By End-User
Home Care
Hospitals
Clinics
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Biocon Ltd
Ceuru Corp
Debiotech SA
Eli Lilly and Company
Embecta Corp
EoFlow CO. Ltd
Haselmeier GmbH
Hindustan Syringes & Medical Devices Ltd
HTL-STREFA S.A.
Insulet Corp
Jiangsu Delfu Medical Device Co. Ltd
MannKind Corp
Medtronic Inc
Medtrum Technologies Inc
Novo Nordisk A/S
Owen Mumford Ltd
Roche Diabetes Care Inc
Sanofi S.A.
Sooil Developments Co. Ltd
Sungshim Medical Co. Ltd
Tandem Diabetes Care Inc
Terumo Corp
Vicentra B.V.
Wockhardt Ltd
Ypsomed Holding AG

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Type
Insulin Pens
-Reusable Insulin Pens
-Disposable Insulin Pens
Insulin Pumps
-Tethered Insulin Pumps
-Tubeless Insulin Pumps
Insulin Pen Needles
-Standard Insulin Pen Needles
-Safety Insulin Pen Needles
Insulin Syringes
Others
By End-User
Home Care
Hospitals
Clinics
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)